Page last updated: 2024-12-06
dowtherm
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 24670 |
| SCHEMBL ID | 432857 |
| MeSH ID | M0100752 |
Synonyms (34)
| Synonym |
|---|
| hsdb 137 |
| dowtherm |
| dinyl |
| 1,1'-biphenyl, mixt. with 1,1'-oxybis(benzene) |
| dinil |
| phenyl ether, compd with biphenyl |
| therminol vp |
| diphyl |
| dowtherm a |
| FT-0651145 |
| A839819 |
| 8004-13-5 |
| 1,1'-biphenyl compound with oxydibenzene (1:1) |
| AKOS015918382 |
| phenyl ether-biphenyl eutectic |
| SCHEMBL432857 |
| dowtherm-a |
| diphenyl ether biphenyl |
| dowtherm(r) a |
| dow-therm-a |
| phenyl ether biphenyl |
| phph phoph |
| MHCVCKDNQYMGEX-UHFFFAOYSA-N |
| dowtherm(r)a |
| biphenyl diphenyl ether |
| DTXSID9073387 |
| mfcd00148859 |
| phenyl ether-biphenyl eutectic(w/w=7/3) |
| CS-W023124 |
| 1,1'-biphenyl compound with oxydibenzene |
| biphenyl diphenyl ether eutectic |
| biphenyl compound with oxydibenzene (1:1) |
| 1,1'-biphenyl;phenoxybenzene |
| F71169 |
Research Excerpts
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (6)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 44.29
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (44.29) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 1 (12.50%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (87.50%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||